Acquiring Company
Jasper Therapeutics
Acquired Company
Kira Pharmaceuticals
Redwood CityCambridgeBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
Jasper Therapeutics has completed the acquisition of Kira Pharmaceuticals in an all-stock transaction. This merger positions the combined company to advance a portfolio of biologic agents aimed at treating immunologically-driven disorders. A concurrent private investment of $132 million is expected to support operations through 2028. The transaction is seen as a transformative step for bringing leading therapies to patients.
Who to call at Jasper Therapeutics, and when
When Jasper Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Jasper Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jasper Therapeutics, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jasper Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Kira Pharmaceuticals?
Kira Pharmaceuticals was acquired by Jasper Therapeutics, based in Redwood City. The deal was reported on July 16, 2026. Our mission is to make safer and potentially curative therapy possible for more patients in need. Jasper Therapeutics is publicly traded (JSPR) and operates in Biotechnology.
When did Jasper Therapeutics acquire Kira Pharmaceuticals?
Jasper Therapeutics's acquisition of Kira Pharmaceuticals was reported on July 16, 2026. Jasper Therapeutics has completed the acquisition of Kira Pharmaceuticals in an all-stock transaction. This merger positions the combined company to advance a portfolio of biologic agents aimed at treating immunologically-driven disorders. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kira Pharmaceuticals do?
Kira Pharmaceuticals was engaged in designing complement therapies to treat immune-mediated diseases. The company aimed to develop innovative biologic agents with dual mechanisms of action. It is privately held, operating in Biotechnology, and is based in Cambridge.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.